Browsing: drug
stocknsharesCardiology stocks will be back in the spotlight this weekend when the American College of Cardiology’s annual scientific meeting gets…
Senate Puts Drug Cartels at Top of Threat List – Key Implications for USD, Security Stocks, and China Trade TensionsFBI…
koto_feja Zai Lab Limited (NASDAQ:ZLAB) announced Thursday that Chinese regulators accepted its marketing application for the cervical cancer therapy Tivdak…
Erik S. Lesser/Getty Images NewsMerck (NYSE:MRK) said that data from a pair of late-stage trials showed that an oral, two-drug…
Justin Sullivan/Getty Images NewsGilead (NASDAQ:GILD) on Tuesday announced encouraging initial data from an ongoing Phase 1 trial for lenacapavir, an…
Mar. 08, 2025 1:30 PM ETMerck & Co., Inc. (MRK) Stock, LLY Stock, NVS Stock, NVO Stock, AZN Stock, ALT…
peterschreiber.mediaGuggenheim has initiated coverage of Metsera (NASDAQ:MTSR) with a buy rating, citing the company’s obesity drug candidates. The bank highlighted…
Victor GolmerMakers of copycat versions of Novo Nordisk’s (NVO) popular weight-loss drug semaglutide, also known as Ozempic and Wegovy, are…
Alexandros MichailidisPfizer (NYSE:PFE) has decided to end R&D and marketing activities related to Beqvez, a one-time gene therapy the company…
kyolshinShares of Arcus Biosciences (NYSE:RCUS) hit a new 52-week low on Tuesday after the biotech said that Gilead Sciences’ (NASDAQ:GILD)…